Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Core 60/40 Balanced Allocation ETF (NY:AOR)

64.55 -0.24 (-0.37%)
Official Closing Price Updated: 8:00 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 482,448
Open 64.77
Bid (Size) 63.79 (100)
Ask (Size) 68.35 (100)
Prev. Close 64.79
Today's Range 64.44 - 64.89
52wk Range 52.97 - 65.78
Shares Outstanding 415,000
Dividend Yield 1.66%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Uber Delivers Solid Earnings, But Tepid Q4 Guidance Sends Stock Lower
Via Stocktwits
Pfizer Raises Full-Year Earnings Guidance, Q3 Numbers Beat Street Estimates
The company noted that it is on track to deliver about $7.2 billion in overall anticipated net cost savings by the end of 2027. 
Via Stocktwits
Topics Artificial Intelligence World Trade

Performance

YTD
+12.8%
+12.8%
1 Month
+0.2%
+0.2%
3 Month
+4.2%
+4.2%
6 Month
+11.2%
+11.2%
1 Year
+10.4%
+10.4%

More News

Read More
American Airlines Names Aviation Veteran Nathaniel Pieper As Chief Commercial Officer
Via Stocktwits
Topics Artificial Intelligence
Polaris Stock Gets Price Target Hikes After Selling Indian Bike Business To Private Equity Firm
Via Stocktwits
Ford CEO Jim Farley Reportedly Expects US EV Demand To Decline Sharply – Here’s Why
Via Stocktwits
Acadia Healthcare Stock Surges Pre-Market After Activist Hedge Fund Reportedly Seeks Board Revamp
Via Stocktwits
Moderna Says Updated mNEXSPIKE Covid Shot Demonstrated Robust Immune Response In Study
Via Stocktwits
BWXT Shares Climb On Department Of Energy’s $1.5B Contract
Via Stocktwits
RH Stock Sees Slew Of Downgrades, Price Target Cuts From Wall Street As Trump Tariffs Bite
Via Stocktwits
Topics Government
Harmony Biosciences Stock Slumps After Rare Genetic Disorder Drug Fails Late-Stage Study
Via Stocktwits
Acadia Pharmaceuticals’ Investigational Drug For Rare Genetic Disorder Fails In Late-Stage Study
Via Stocktwits
Legend Biotech Considering Second Listing Outside US: Report
Via Stocktwits
Hertz Expands Program Allowing Prolonged 3-Day Test Drives Before Vehicle Purchase To Over 100 Cities
Via Stocktwits
Schrödinger Discontinues Clinical Program After Two Patient Deaths
Via Stocktwits
Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’
Via Stocktwits
Baxter Appoints Andrew Hider To Succeed Jose Almeida As CEO: Retail Sentiment Falters
Via Stocktwits
60/40 Portfolio Bounces Back From 2022 Slump: Is It The Right Investment Strategy For 2024?
Via Benzinga

Frequently Asked Questions

Is iShares Core 60/40 Balanced Allocation ETF publicly traded?
Yes, iShares Core 60/40 Balanced Allocation ETF is publicly traded.
What exchange does iShares Core 60/40 Balanced Allocation ETF trade on?
iShares Core 60/40 Balanced Allocation ETF trades on the New York Stock Exchange
What is the ticker symbol for iShares Core 60/40 Balanced Allocation ETF?
The ticker symbol for iShares Core 60/40 Balanced Allocation ETF is AOR on the New York Stock Exchange
What is the current price of iShares Core 60/40 Balanced Allocation ETF?
The current price of iShares Core 60/40 Balanced Allocation ETF is 64.55
When was iShares Core 60/40 Balanced Allocation ETF last traded?
The last trade of iShares Core 60/40 Balanced Allocation ETF was at 11/06/25 08:00 PM ET
What is the market capitalization of iShares Core 60/40 Balanced Allocation ETF?
The market capitalization of iShares Core 60/40 Balanced Allocation ETF is 26.79M
How many shares of iShares Core 60/40 Balanced Allocation ETF are outstanding?
iShares Core 60/40 Balanced Allocation ETF has 27M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.